{"name": "Drug Response Dx",
 "permalink": "drug-response-dx",
 "crunchbase_url": "http://www.crunchbase.com/company/drug-response-dx",
 "homepage_url": "http://www.drugresponsedx.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": 2012,
 "founded_month": 2,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@drugresponsedx.com",
 "phone_number": "49-(0)-3302-55199-85",
 "description": "",
 "created_at": "Wed Jan 09 12:44:21 UTC 2013",
 "updated_at": "Wed Jan 09 12:50:10 UTC 2013",
 "overview": "\u003Cp\u003EDrug Response Dx is based in Hennigsdorf, Germany and was founded in February 2012 by Dr. Zolt\u00e1n Konthur, Dr. J\u00f6rg-M. \nHollidt, Dr. Karl Skriner and Dr. Joachim Rautter. The biomarker set is prevalidated; the biochemicals and test samples \nare present. The proof of concept in serums from RA patients is established. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       54],
      "assets/images/resized/0022/8836/228836v1-max-150x150.jpg"],
     [[250,
       90],
      "assets/images/resized/0022/8836/228836v1-max-250x250.jpg"],
     [[314,
       114],
      "assets/images/resized/0022/8836/228836v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2013/01/drug-response-dx-closes-financing.html",
    "source_description": "Drug Response Dx Closes First Round of Financing",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2013,
    "funded_month": 1,
    "funded_day": 8,
    "investments":
     [{"company":
        {"name": "Qiagen",
         "permalink": "qiagen",
         "image":
          {"available_sizes":
            [[[104,
               78],
              "assets/images/resized/0005/9941/59941v1-max-150x150.png"],
             [[104,
               78],
              "assets/images/resized/0005/9941/59941v1-max-250x250.png"],
             [[104,
               78],
              "assets/images/resized/0005/9941/59941v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "High-Tech Gruenderfonds",
         "permalink": "high-tech-gruenderfonds",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/8109/28109v4-max-150x150.jpg"],
             [[250,
               69],
              "assets/images/resized/0002/8109/28109v4-max-250x250.jpg"],
             [[450,
               125],
              "assets/images/resized/0002/8109/28109v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Neuendorfstr. 17",
    "address2": "",
    "zip_code": "16761",
    "city": "Hennigsdorf",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        119],
       "assets/images/resized/0022/8837/228837v1-max-150x150.jpg"],
      [[250,
        198],
       "assets/images/resized/0022/8837/228837v1-max-250x250.jpg"],
      [[450,
        358],
       "assets/images/resized/0022/8837/228837v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}